Erythrocyte membrane-encapsulated celecoxib improves the cognitive decline of Alzheimer's disease by concurrently inducing neurogenesis and reducing apoptosis in APP/PS1 transgenic mice-Reference-Cited by-同舟云学术

Erythrocyte membrane-encapsulated celecoxib improves the cognitive decline of Alzheimer's disease by concurrently inducing neurogenesis and reducing apoptosis in APP/PS1 transgenic mice

Published:2017-11 Issue: Volume:145 Page:106-127
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Guo Jing-Wen,Guan Pei-Pei,Ding Wei-Yan,Wang Si-Ling,Huang Xue-Shi,Wang Zhan-You,Wang Pu

Funder

National Natural Science Foundation of China

Fundamental Research Funds of China

National Natural Science Foundation of Liaoning, China

Liaoning Provincial Talent Support Program

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference105 articles.

1. The role of amyloid beta in the pathogenesis of Alzheimer's disease;Gilbert;J. Clin. Pathol.,2013

2. Environmental enrichment stimulates neurogenesis in apolipoprotein E3 and neuronal apoptosis in apolipoprotein E4 transgenic mice;Levi;J. Neurochem.,2007

3. Neurogenesis in the aged and neurodegenerative brain;Shruster;Apoptosis Int. J. Program. Cell Death,2010

4. Stimulatory effects of prostaglandin E2 on neurogenesis in the dentate gyrus of the adult rat;Uchida;Zool. Sci.,2002

5. Prostaglandin E2 contributes to the synthesis of brain-derived neurotrophic factor in primary sensory neuron in ganglion explant cultures and in a neuropathic pain model;Cruz Duarte;Exp. Neurol.,2012

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroprotective efficiency of celecoxib vesicular bilosomes for the management of lipopolysaccharide-induced Alzheimer in mice employing 23 full factorial design;Inflammopharmacology;2024-07-17

2. The Potential Mechanism of Eriodictyol in Treating Alzheimer's Disease: A Study on Computer-assisted Investigational Strategies;Current Pharmaceutical Design;2024-07

3. Unveiling the impact of aging on BBB and Alzheimer's disease: Factors and therapeutic implications;Ageing Research Reviews;2024-07

4. An Overview on the Physiopathology of the Blood–Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery;Pharmaceutics;2024-06-22

5. Hybrid Membrane‐Coated Nanoparticles for Precise Targeting and Synergistic Therapy in Alzheimer's Disease;Advanced Science;2024-04-22